Plasma renin exists in an active form or as an inactive zymogen that resembles a prorenin present in homogenates of human kidneys. We examined the relation of diabetes and its microvascular complications with the level of plasma inactive renin activated by dialysis to pH 3.3. Plasma inactive renin was measured in 235 diabetic patients and 90 nondiabetic controls. In the controls, the level of plasma inactive renin increased slightly with age but was never above 50 ng per milliliter per hour. In young diabetic patients studied within three years of the onset of diabetes the concentration of inactive renin was normal, and in some older diabetics without complications it remained within the age-adjusted normal range for many years. However, in patients with retinopathy or albuminuria, plasma inactive renin was above the normal range with few exceptions, reaching levels 50 to 200 per cent above the upper limits of normal in patients with nephropathy. The frequency of neuropathy was also significantly higher among patients with levels above the normal range. In 37 per cent of the diabetics followed during one to three years of conventional treatment, plasma inactive renin increased significantly, but in another group of diabetics under intensive treatment, the level rose in only 7 per cent and fell in 43 per cent. We conclude that there is a close association between a high level of plasma inactive renin and the presence of microvascular complications, and that the level of inactive renin can be modified by intensive treatment of diabetes.
This article has been cited by other articles:
Singh, V. P., Le, B., Khode, R., Baker, K. M., Kumar, R.
(2008). Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis. Diabetes
57: 3297-3306
[Abstract][Full Text]
Wilkinson-Berka, J. L.
(2008). Prorenin and the (Pro)renin Receptor in Ocular Pathology. Am. J. Pathol.
173: 1591-1594
[Abstract][Full Text]
Zhang, J., Noble, N. A., Border, W. A., Owens, R. T., Huang, Y.
(2008). Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells. Am. J. Physiol. Endocrinol. Metab.
295: E810-E819
[Abstract][Full Text]
Parving, H.-H., Persson, F., Lewis, J. B., Lewis, E. J., Hollenberg, N. K., the AVOID Study Investigators,
(2008). Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy. NEJM
358: 2433-2446
[Abstract][Full Text]
Kang, J. J., Toma, I., Sipos, A., Meer, E. J., Vargas, S. L., Peti-Peterdi, J.
(2008). The Collecting Duct Is the Major Source of Prorenin in Diabetes. Hypertension
51: 1597-1604
[Abstract][Full Text]
Nguyen, G., Danser, A. H. J.
(2008). Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents. Exp Physiol
93: 557-563
[Abstract][Full Text]
Feldt, S., Maschke, U., Dechend, R., Luft, F. C., Muller, D. N.
(2008). The Putative (Pro)renin Receptor Blocker HRP Fails to Prevent (Pro)renin Signaling. J. Am. Soc. Nephrol.
19: 743-748
[Abstract][Full Text]
Feldt, S., Batenburg, W. W., Mazak, I., Maschke, U., Wellner, M., Kvakan, H., Dechend, R., Fiebeler, A., Burckle, C., Contrepas, A., Jan Danser, A.H., Bader, M., Nguyen, G., Luft, F. C., Muller, D. N.
(2008). Prorenin and Renin-Induced Extracellular Signal-Regulated Kinase 1/2 Activation in Monocytes Is Not Blocked by Aliskiren or the Handle-Region Peptide. Hypertension
51: 682-688
[Abstract][Full Text]
Muller, D. N., Klanke, B., Feldt, S., Cordasic, N., Hartner, A., Schmieder, R. E., Luft, F. C., Hilgers, K. F.
(2008). (Pro)Renin Receptor Peptide Inhibitor "Handle-Region" Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats. Hypertension
51: 676-681
[Abstract][Full Text]
Gradman, A. H., Kad, R.
(2008). Renin inhibition in hypertension.. J Am Coll Cardiol
51: 519-528
[Abstract][Full Text]
Senanayake, P. deS., Drazba, J., Shadrach, K., Milsted, A., Rungger-Brandle, E., Nishiyama, K., Miura, S.-I., Karnik, S., Sears, J. E., Hollyfield, J. G.
(2007). Angiotensin II and Its Receptor Subtypes in the Human Retina. IOVS
48: 3301-3311
[Abstract][Full Text]
Luft, F. C.
(2007). Renin and Its Putative Receptor Remain Enigmas. J. Am. Soc. Nephrol.
18: 1989-1992
[Full Text]
Takahashi, H., Ichihara, A., Kaneshiro, Y., Inomata, K., Sakoda, M., Takemitsu, T., Nishiyama, A., Itoh, H.
(2007). Regression of Nephropathy Developed in Diabetes by (Pro)renin Receptor Blockade. J. Am. Soc. Nephrol.
18: 2054-2061
[Abstract][Full Text]
Suzuki, F.
(2007). Nonproteolytic activation of prorenin by the (pro)renin receptor is blocked by decoy peptide. Journal of Renin-Angiotensin-Aldosterone System
8: 101-103
Jan Danser, A. H., Batenburg, W. W., van Esch, J. H. M.
(2007). Prorenin and the (pro)renin receptor--an update. Nephrol Dial Transplant
22: 1288-1292
[Full Text]
Messerli, F. H., Re, R. N.
(2007). Do We Need Yet Another Blocker of the Renin-Angiotensin System?. J Am Coll Cardiol
49: 1164-1165
[Full Text]
Ichihara, A.
(2006). Resolving the mysteries of the renin-angiotensin system in diabetes. Journal of Renin-Angiotensin-Aldosterone System
7: 250-251
Stankovic, A. R., Fisher, N. D.L., Hollenberg, N. K.
(2006). Prorenin and Angiotensin-Dependent Renal Vasoconstriction in Type 1 and Type 2 Diabetes. J. Am. Soc. Nephrol.
17: 3293-3299
[Abstract][Full Text]
Paul, M., Poyan Mehr, A., Kreutz, R.
(2006). Physiology of local Renin-Angiotensin systems.. Physiol. Rev.
86: 747-803
[Abstract][Full Text]
Jan Danser, A.H.
(2006). Prorenin: Back Into the Arena. Hypertension
47: 824-826
[Full Text]
Weinberger, M. H.
(2006). John Arthur Luetscher, Jr (1913-2005). Hypertension
47: 627-628
[Full Text]
Muller, D. N., Luft, F. C.
(2006). Direct Renin Inhibition with Aliskiren in Hypertension and Target Organ Damage. CJASN
1: 221-228
[Abstract][Full Text]
Burckle, C. A., Jan Danser, A.H., Muller, D. N., Garrelds, I. M., Gasc, J.-M., Popova, E., Plehm, R., Peters, J., Bader, M., Nguyen, G.
(2006). Elevated Blood Pressure and Heart Rate in Human Renin Receptor Transgenic Rats. Hypertension
47: 552-556
[Abstract][Full Text]
Yokota, H, Mori, F, Kai, K, Nagaoka, T, Izumi, N, Takahashi, A, Hikichi, T, Yoshida, A, Suzuki, F, Ishida, Y
(2005). Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay. Br. J. Ophthalmol.
89: 871-873
[Abstract][Full Text]
Suzuki, F., Hayakawa, M., Nakagawa, T., Nasir, U. M., Ebihara, A., Iwasawa, A., Ishida, Y., Nakamura, Y., Murakami, K.
(2003). Human Prorenin Has "Gate and Handle" Regions for Its Non-proteolytic Activation. J. Biol. Chem.
278: 22217-22222
[Abstract][Full Text]
Peters, J., Farrenkopf, R., Clausmeyer, S., Zimmer, J., Kantachuvesiri, S., Sharp, M. G.F., Mullins, J. J.
(2002). Functional Significance of Prorenin Internalization in the Rat Heart. Circ. Res.
90: 1135-1141
[Abstract][Full Text]
Hoeldtke, R. D., Bryner, K. D., Komanduri, P., Christie, I., Ganser, G., Hobbs, G. R.
(2000). Decreased Prorenin Processing Develops before Autonomic Dysfunction in Type 1 Diabetes. J. Clin. Endocrinol. Metab.
85: 585-589
[Abstract][Full Text]
Deinum, J., Tarnow, L., van Gool, J. M., de Bruin, R. A., Derkx, F. H. M., Schalekamp, M. A. D. H., Parving, H.-H.
(1999). Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy. Nephrol Dial Transplant
14: 1904-1911
[Abstract][Full Text]
Mäkimattila, S., Summanen, P., Matinlauri, I., Mäntysaari, M., Schlenzka, A., Aalto, M., Irjala, K., Yki-Järvinen, H.
(1998). Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM. Br. J. Ophthalmol.
82: 939-944
[Abstract][Full Text]
Hilgers, K. F., Reddi, V., Krege, J. H., Smithies, O., Gomez, R. A.
(1997). Aberrant Renal Vascular Morphology and Renin Expression in Mutant Mice Lacking Angiotensin-Converting Enzyme. Hypertension
29: 216-221
[Abstract][Full Text]
Previous
